Sanofi to sue Dr. Reddy's on generic Plavix
French drug major Sanofi-Synthelabo said on Wednesday that it would take legal action against the Rs 984-crore Dr. Reddy's Laboratories (DRL), which plans to launch a generic version of Sanofi's
French drug major Sanofi-Synthelabo said on Wednesday that it would take legal action against the Rs 984-crore Dr. Reddy's Laboratories (DRL), which plans to launch a generic version of Sanofi's